Neonatal hypoglycaemia · Infants of women diagnosed with gestational diabetes
Metformin showed no clear difference in neonatal hypoglycaemia compared with glibenclamide ‐ neonatal outcomes (low certainty).
1 finding from 1 review
Adiposity ‐ not reported · Infants of women diagnosed with gestational diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diabetes ‐ not measured · Infants of women diagnosed with gestational diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurosensory disability in later childhood ‐ not measured · Infants of women diagnosed with gestational diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypertensive disorders of pregnancy ‐ not reported · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caesarean section · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
Glibenclamide showed no clear difference in caesarean section compared with acarbose ‐ maternal outcomes (low certainty).
1 finding from 1 review
Development of type 2 diabetes ‐ not measured · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perineal trauma ‐ not reported · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Return to pre‐pregnancy weight ‐ not measured · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Postnatal depression ‐ not measured · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Induction of labour ‐ not reported · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Large‐for‐gestational age · women with gestational diabetes mellitus
Glibenclamide showed no clear difference in large‐for‐gestational age compared with acarbose ‐ neonatal outcomes (low certainty).
1 finding from 1 review
Perinatal mortality · women with gestational diabetes mellitus
1 finding from 1 review
Death or serious morbidity composite · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal hypoglycaemia · women with gestational diabetes mellitus
Glibenclamide showed no clear difference in neonatal hypoglycaemia compared with acarbose ‐ neonatal outcomes (low certainty).
1 finding from 1 review
Adiposity ‐ not reported · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diabetes ‐ not reported · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurosensory disability in later childhood ‐ not measured · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Substantial benefit: At least 50% reduction in pain, or PGIC much improved · adults with fibromyalgia
It is very uncertain whether NSAID changes substantial pain relief: at least 50% reduction in pain, or PGIC… compared with placebo (very low certainty).
1 finding from 1 review
Moderate benefit: At least 30% reduction in pain, or PGIC much or very much improved · adults with fibromyalgia
It is very uncertain whether NSAID changes moderate pain relief: at least 30% reduction in pain, or PGIC much… compared with placebo (very low certainty).
1 finding from 1 review